Member Info for Louis_Winthorp

His buy high - sell low strategy is ballsy but isn't for everyone...!

*grinning emoji*

Bring it on. NCYT don't seem to have much to say, unless they are waiting for April to tell us what we think we are seeing now!

You too on ARB. xx

I was on the email list but they stopped a while ago.

No replies from emails sent either.

(AKA the Grim Reaper) will be pleased to see this!

LSE's Grim Reaper is back!

My thoughts...

Still not decided what to have for dinner tomorrow... decisions decisions...

The Grim Reaper of LSE.

Nothing good to say about any share he posts on.

B2.

I think the forward looking plan put out yesterday for LTIP for executives is one thing.

If there is a plan to chase II investment, they would be asking DA how he plans to get things moving, what's in the pipeline etc...

Institutions chucking other peoples money at the buying of shares get to meet the CEO and grill him over the plans.

It will be interesting to see if DA wants to go down that route.

There has been a lot of talk on this BB for more than 18 months about Institutional Investment and how it would benefit. We know the last CEO wasn't too keen.

Just my take.

GM also wasn't interested in II too.

His plan was to grow the company his way

Maybe DA sees a place for II going forward? He has to show signs of delivering a forward looking plan to get them interested first.

He'll know that as well as strong performance, communication with shareholders and the market is imperative. That is a huge part of the share price erosion over the last year. A growing company should be protecting the share price as a sign of strength and confidence.

If £95m revenues is a dog, we should all give up!

There is whole world out there and we are still selling in to it.

British government and DHSC have proved to be untrustworthy and bad payers. NCYT would do well to keep them at arms length.

It has been NCYT's strategy to maximise Covid testing revenues, they should know the whether there is the demand for their offerings. I'm sure we don't have 8 more tests on the horizon because R&D are bored in the lab!

I'll be giving the company more time as this current valuation is an absolute joke.

Just my opinion...

Cheers for that info, JamesRobbo.

I've been searching for the name of this company. Does anybody here remember it?

They RNS'd their resolution last Summer.

There was a company who's name I can't remember, who after about 7 months of dispute, the DHSC paid up to the tune of around £30m. As far as I remember, they only had an agreement to supply.

We have actually supplied in good faith and offered to remedy the problem at our own expense.

We all know Boris has only gone down the 'quick, let's get rid of all restrictions, so they all forget about the parties' route to save his arse.

Sue Gray's report must've been eaten by one of those dogs rescued from Afghanistan!

I jumped the gun with my reply.

Should've added , we have a government that now thinks we are all clear.

I know what you mean about PCR being used for testing for other things. It's the point NCYT were going all out to make the most of Covid testing and we've missed out on having our offering out there for months. Might've helped get the dispute sorted out quicker too! Purely UK slant on my post. Hopefully, it will be available soon and do well in to our already established worldwide sales.

That 10 minute PCR would've shaken things up if it had came out on time!

R&D will get us so far, like you say, it burns funds. News regarding the right acquisition would be better, as it would add value and show real intent going forward.

I really thought we would make one last year, but nothing.

Can't argue with any of that.

*thumbs up emoji*